The prevalence of glaucoma has gradually increased in recent years, and drug discovery and development efforts for the ocular field continue to be explored and advanced. As more new therapies are developed, the need for a broad range of glaucoma disease models has increased. In vivo or in vitro models that mimic the human glaucoma state can be utilized to validate a new therapeutic approach.

As a specialized glaucoma research company, Ace Ophthalmology provides unique preclinical services in glaucoma research to researchers at academic institutions and pharmaceutical companies. Our services cover in vivo and in vitro studies to investigate the method of action and effect of drug candidates in the eye to identify effective treatments and therapeutic targets.

Learn more：glaucoma in vitro research services